We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
3NT will use the funds to complete its family of specialty single-use endoscope and therapeutic devices and initiate commercialization of Sinusway platform in the US and Europe, advancing
The Series C financing was led by Temasek with new and existing investors including Baillie Gifford, Amgen Ventures, M Ventures, JAZZ Venture Partners, Canepa Advanced Healthcare Funds, and
Olympus designs and delivers solutions for medical and surgical procedures. ai4gi is a commercial joint venture between Satis Operations and Imagia. Olympus America will exclusively offer the AI
The medical device-maker is focused on improving treatment for acute myocardial infarction (AMI). TherOx will use the proceeds to support the US market introduction and commercialization of its SuperSaturated Oxygen
The device will offer temporary relief of sinus pain by harnessing the body’s natural electrical system. The tip of the device is applied only to the outside of
The round was led by Wildcat Capital Management and joined by J&J Innovation, Nikon-SBI Innovation Fund, Whittier Ventures and VSP Global. NeuroVision’s noninvasive, eye imaging system is designed
The platform will help IT, security and clinical engineering teams of healthcare providers in strengthening their cyber security posture and reducing risk across their medical device fleet. Nuvolo’s
The three-year collaboration will see Verily deploy its Immunoscape platform to generate insights from Gilead clinical trials. Verily’s Immunoscape platform will be used to identify and better understand
Crohn’s disease is one of the major forms of inflammatory bowel disease. The study is sponsored by Cambridge University Hospital NHS Foundation Trust and the University of Cambridge.